Heart Failure Clinical Trial
Official title:
Medico-economic Evaluation of Strategies for the Lead Extraction of Implantable Defibrillator and Pacemakers: a Retrospective Observational Study
The growing use and the expanding indications for cardiovascular implantable electronic
devices (CIEDs) have been associated to an increase of device removal. The indications of
CIEDs removal are infectious (55%) or noninfectious (45%) such as upgrading of devices,
nonfunctional devices and thrombosis. Removal can be performed according to transvenous or
surgical procedures. Transvenous lead removal (TLR) must be done by experimented
cardiologists and respecting current consensus. TLR can be done with conventional techniques
involving inserting locking stylets and telescoping sheaths around the pacing leads to
separate them from the surrounding scar tissue. These conventional procedures have a success
rate of ≈65%. TLR thanks to laser sheath has been validated and improved the success rate
until >95%. However, the TLR from chronically implanted CIEDs still carries a significant
risk of procedural failure, morbidity, and mortality, related to tearing of the great vessels
and cardiac structures, even when performed by experienced operators. Even if the transvenous
extraction using laser sheath seems to be more effective, this strategy would be more
expensive.
Considering the availability of several strategies for TLR and the cost heterogeneity of
procedures, a cost assessment in real life of these therapeutic strategies is essential for
an optimal choice of therapeutic strategies.
The study will compare the strategies of percutaneous extraction to surgical extraction.
- Mechanical percutaneous extraction is the conventional technique using locking stylets
and telescoping sheaths around the pacing leads to separate them from the surrounding
scar tissue.
- Laser-assisted lead extraction is most often used in complex procedures and dissolves
rather than tear the scar tissue.
- Sternotomy is the surgical procedure used when leads cannot be removed by percutaneous
extraction. It is rarely employed.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05654272 -
Development of CIRC Technologies
|
||
Recruiting |
NCT05196659 -
Collaborative Quality Improvement (C-QIP) Study
|
N/A | |
Recruiting |
NCT05650307 -
CV Imaging of Metabolic Interventions
|
||
Active, not recruiting |
NCT05896904 -
Clinical Comparison of Patients With Transthyretin Cardiac Amyloidosis and Patients With Heart Failure With Reduced Ejection Fraction
|
N/A | |
Completed |
NCT05077293 -
Building Electronic Tools To Enhance and Reinforce Cardiovascular Recommendations - Heart Failure
|
||
Recruiting |
NCT05631275 -
The Role of Bioimpedance Analysis in Patients With Chronic Heart Failure and Systolic Ventricular Dysfunction
|
||
Enrolling by invitation |
NCT05564572 -
Randomized Implementation of Routine Patient-Reported Health Status Assessment Among Heart Failure Patients in Stanford Cardiology
|
N/A | |
Enrolling by invitation |
NCT05009706 -
Self-care in Older Frail Persons With Heart Failure Intervention
|
N/A | |
Recruiting |
NCT04177199 -
What is the Workload Burden Associated With Using the Triage HF+ Care Pathway?
|
||
Terminated |
NCT03615469 -
Building Strength Through Rehabilitation for Heart Failure Patients (BISTRO-STUDY)
|
N/A | |
Recruiting |
NCT06340048 -
Epicardial Injection of hiPSC-CMs to Treat Severe Chronic Ischemic Heart Failure
|
Phase 1/Phase 2 | |
Recruiting |
NCT05679713 -
Next-generation, Integrative, and Personalized Risk Assessment to Prevent Recurrent Heart Failure Events: the ORACLE Study
|
||
Completed |
NCT04254328 -
The Effectiveness of Nintendo Wii Fit and Inspiratory Muscle Training in Older Patients With Heart Failure
|
N/A | |
Completed |
NCT03549169 -
Decision Making for the Management the Symptoms in Adults of Heart Failure
|
N/A | |
Recruiting |
NCT05572814 -
Transform: Teaching, Technology, and Teams
|
N/A | |
Enrolling by invitation |
NCT05538611 -
Effect Evaluation of Chain Quality Control Management on Patients With Heart Failure
|
||
Recruiting |
NCT04262830 -
Cancer Therapy Effects on the Heart
|
||
Completed |
NCT06026683 -
Conduction System Stimulation to Avoid Left Ventricle Dysfunction
|
N/A | |
Withdrawn |
NCT03091998 -
Subcu Administration of CD-NP in Heart Failure Patients With Left Ventricular Assist Device Support
|
Phase 1 | |
Recruiting |
NCT05564689 -
Absolute Coronary Flow in Patients With Heart Failure With Reduced Ejection Fraction and Left Bundle Branch Block With Cardiac Resynchronization Therapy
|